We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current NXEN market cap is 1.3M. The company's latest EPS is USD -0.0054 and P/E is -3.70.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.3M | -2.67M | -1.84M | -564k | -283k |
| Net Income | -4.3M | -2.67M | -1.86M | -626k | -362k |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 311k | 23k | 26k | 125k | 43k |
| Total Liabilities | 45k | 29k | 40k | 242k | 295k |
| Total Equity | 266k | -6k | -14k | -117k | -252k |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -644k | -147k | -91k | -75k | -82k |
| Investing | -30k | N/A | N/A | N/A | N/A |
| Financing | N/A | 12k | 98k | 174k | N/A |
| Market Cap | 1.3M |
| Price to Earnings Ratio | -3.70 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 40 |
| Price to Book Ratio | -5.35 |
| Dividend Yield | - |
| Shares Outstanding | 67.47M |
| Average Volume (1 week) | 13.44k |
| Average Volume (1 Month) | 27.13k |
| 52 Week Change | -19.58% |
| 52 Week High | 0.0429 |
| 52 Week Low | 0.011 |
| Spread (Intraday) | 0.02 (55.01%) |
| Company Name | Nexien BioPharma Inc (PK) |
| Address |
16192 coastal highway lewes, delaware 19958 |
| Website | https://nexienbiopharma.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
